Literature DB >> 32430419

Cardiac function and pulmonary hypertension in Central Asian highlanders at 3250 m.

Mona Lichtblau1,2, Stéphanie Saxer1,2, Michael Furian1, Laura Mayer1, Patrick R Bader1, Philipp M Scheiwiller1, Maamed Mademilov3, Ulan Sheraliev3, Felix C Tanner4, Talant M Sooronbaev3, Konrad E Bloch1, Silvia Ulrich5.   

Abstract

THE QUESTION ADDRESSED BY THE STUDY: Chronic exposure to hypoxia increases pulmonary artery pressure (PAP) in highlanders, but the criteria for diagnosis of high-altitude pulmonary hypertension (HAPH) are debated. We assessed cardiac function and PAP in highlanders at 3250 m and explored HAPH prevalence using different definitions. PATIENTS AND METHODS: Central Asian highlanders free of overt cardiorespiratory disease, permanently living at 2500-3500 m compared to age-matched lowlanders living <800 m. Participants underwent echocardiography close to their altitude of residence (at 3250 m versus 760 m).
RESULTS: 173 participants (97 highlanders, 76 lowlanders), mean±sd age 49±9 years (49% females) completed the study. Results in lowlanders versus highlanders were systolic PAP (23±5 versus 30±10 mmHg), right ventricular fractional area change (42±6% versus 39±8%), tricuspid annular plane systolic excursion (2.1±0.3 versus 2.0±0.3 cm), right atrial volume index (20±6 versus 23±8 mL·m-2), left ventricular ejection fraction (62±4% versus 57±5%) and stroke volume (64±10 versus 57±11 mL); all between-group comparisons p<0.05. Depending on criteria, HAPH prevalence varied between 6% and 35%. THE ANSWER TO THE QUESTION: Chronic exposure to hypoxia in highlanders is associated with higher PAP and slight alterations in right and left heart function compared to lowlanders. The prevalence of HAPH in this large highlander cohort varies between 6% according to expert consensus definition of chronic high-altitude disease to 35% according to the most recent definition of pulmonary hypertension proposed for lowlanders.
Copyright ©ERS 2020.

Entities:  

Mesh:

Year:  2020        PMID: 32430419     DOI: 10.1183/13993003.02474-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  4 in total

1.  Cardiac Adaptation to Prolonged High Altitude Migration Assessed by Speckle Tracking Echocardiography.

Authors:  Xu Chen; Bohan Liu; Yujiao Deng; Feifei Yang; Wenjun Wang; Xixiang Lin; Liheng Yu; Haitao Pu; Peifang Zhang; Zongren Li; Qin Zhong; Qian Jia; Yao Li; Xiao Wang; Wei Chen; Daniel Burkhoff; Kunlun He
Journal:  Front Cardiovasc Med       Date:  2022-05-23

2.  Cardiorespiratory Adaptation to Short-Term Exposure to Altitude vs. Normobaric Hypoxia in Patients with Pulmonary Hypertension.

Authors:  Simon R Schneider; Mona Lichtblau; Michael Furian; Laura C Mayer; Charlotte Berlier; Julian Müller; Stéphanie Saxer; Esther I Schwarz; Konrad E Bloch; Silvia Ulrich
Journal:  J Clin Med       Date:  2022-05-14       Impact factor: 4.964

3.  Effect of a day-trip to altitude (2500 m) on exercise performance in pulmonary hypertension: randomised crossover trial.

Authors:  Simon R Schneider; Laura C Mayer; Mona Lichtblau; Charlotte Berlier; Esther I Schwarz; Stéphanie Saxer; Lu Tan; Michael Furian; Konrad E Bloch; Silvia Ulrich
Journal:  ERJ Open Res       Date:  2021-10-11

Review 4.  Hypoxia in Aging and Aging-Related Diseases: Mechanism and Therapeutic Strategies.

Authors:  Yaqin Wei; Sergio Giunta; Shijin Xia
Journal:  Int J Mol Sci       Date:  2022-07-25       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.